SINTX Technologies Divests Subsidiary to Strengthen Focus on Medical Devices

February 20, 2025 - 20:13

Salt Lake City, UT, Feb. 20, 2025 – SINTX Technologies, Inc., a prominent player in advanced ceramics for medical applications, has announced the strategic sale of its wholly-owned subsidiary, Technology Assessment and Transfer (TA&T), to Tethon Corporation, also known as Tethon 3D. This pivotal transaction is designed to enhance SINTX’s financial flexibility and sharpen its focus on the burgeoning medical device market.

By divesting TA&T, SINTX aims to streamline its operations and concentrate resources on developing innovative healthcare solutions. The sale is expected to provide the company with additional capital, which will be directed towards advancing its core competencies in medical technologies.

SINTX's leadership believes that this move will not only bolster its competitive edge but also facilitate growth in a sector that is increasingly reliant on cutting-edge materials and manufacturing processes. The company remains committed to its mission of delivering high-quality medical products that improve patient outcomes.